Dr. Andrea Holmes holds a PhD in organic chemistry from New York University and was a National Institute of Health Fellow at Columbia University. She is a tenured Professor of Chemistry and conducted over 25 years of academic and industry research in nanotechnology, anti-biotic resistant biofilm infections, and the pharmacology of cannabinoids. As a Professor, she pioneered an internationally renounced cannabis curriculum at her University. She has created certificates for medical health care and science professionals for several universities in the United States. She is Chief Science Officer at KD Pharma and leads the infant formula ingredient project between two global partnering companies. She served as the global head of KD Phyto, the cannabinoid pharmaceutical business sector of KD Pharma.
Dr. Holmes has founded and co-owns several cannabis companies including testing labs and special formulation companies that focus on the synthesis of minor cannabinoids, and retail. She serves as a worldwide subject matter expert, expert witness, and consultant, including in the US, EU, Brazil, UK, and Thailand.
Dr. Holmes has given local, national, and international lectures and has published two cannabis textbooks, more than 50 peer-reviewed articles and cannabis textbooks on terpenes, endocannabinoid system, major and minor cannabinoids, extraction methods, niche markets like using CBD for the pet industry, and unique topics that involve the rapidly emerging cannabis industry.
Dr. Holmes is passionate about animal rescue and volunteers at Hearts United for Animals. She is a classical ballet dancer and uses cannabinoid-based products to help her pets and herself to prevent and treat injury from her dance.